‘Exciting’ skin cancer vaccine halves risk of relapse or death in study
A cutting-edge skin cancer vaccine being trialled on NHS patients halves the risk of death or relapse, a study found. Given after surgery, the jab is custom built in a matter of weeks to target each patient’s specific cancer mutations. The largest trial to date found it cut the chances of relapse or death for … Read more
